Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.

about

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q54982684

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.

@en

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.

@nl

type

Item

label

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.

@en

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.

@nl

prefLabel

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.

@en

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.

@nl

P1476

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.

@en

P2093

Ayodeji A Asuni

http://www.w3.org/2001/XMLSchema#string

Isabelle L Sumner

http://www.w3.org/2001/XMLSchema#string

Ross A Edwards

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Active and passive immunotherapy for neurodegenerative disorders

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

The amyloid hypothesis of Alzheimer's disease at 25 years

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β

Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation

Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

P304

254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNINS.2018.00254

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jessica L. Teeling

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29740272

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

immunotherapy

P932

5924811

http://www.w3.org/2001/XMLSchema#string